1.Clinical efficacy and influencing factors of Chaihu anxin capsules in the treatment of mild-to-moderate depression
Yaqing LI ; Yupei HAO ; Shizhao YUAN ; Wentao WANG ; Chunhua ZHOU ; Yancong HAN ; Yuanyuan ZHAO ; Zhuo ZHANG ; Shulian FU ; Jing YU
China Pharmacy 2026;37(18):2402-2407
OBJECTIVE To evaluate the clinical efficacy of Chaihu anxin capsules in the treatment of mild-to-moderate depression, analyze the influencing factors of its efficacy, construct a nomogram prediction model.METHODS Patients with mild-to-moderate depression treated at The First Hospital of Hebei Medical University from May 1, 2023 to March 10, 2025 were retrospectively included and categorized into Chaihu anxin capsules group and milnacipran group according to treatment regimen. Propensity score matching (PSM) was used to balance baseline characteristics, and treatment efficacy was compared after 8 weeks, including 24 Hamilton Depression Scale (HAMD-24) scores and changes, Hamilton Anxiety Scale (HAMA) scores and changes, and treatment response rate after 8 weeks of treatment. Patients receiving Chaihu anxin capsules were further classified as responders or non-responders based on the occurrence of treatment response. Univariate and multivariate Logistic regression analyses were conducted to identify the influencing factors of treatment response, and a nomogram model was constructed to predict the probability of treatment response, its predictive performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.RESULTS A total of 297 patients were included before PSM, including 196 patients in the Chaihu anxin capsules group and 101 patients in the milnacipran group. After PSM, each group included 44 patients. After PSM, the HAMD-24 scores and HAMA scores at 8 weeks after treatment in the Chaihu anxin capsules group, as well as the HAMD-24 scores in the milnacipran group, were significantly lower than their respective baseline values ( P <0.05); the change in HAMA score in the Chaihu anxin capsules group was significantly greater than that in the milnacipran group ( P =0.04). Multivariable Logistic regression identified age, total bilirubin, and baseline HAMD-24 score as independent predictors of treatment response ( P <0.05). The area under the ROC curve of the constructed nomogram prediction model was 0.72 (95% confidence interval: 0.637-0.799), and the corrected Brier score was 0.143 (95% confidence interval: 0.112-0.176); compared with the “all intervention” and “all non intervention” strategies, applying this nomogram prediction model could achieve higher net benefits within the threshold probability range of 8% to 37%.CONCLUSIONS The efficacy of Chaihu anxin capsules in improving mild-to-moderate depression is comparable to that of milnacipran, and it has certain advantages in improving anxiety symptoms; age, total bilirubin, and baseline HAMD-24 score are independent influencing factors for the treatment response of Chaihu anxin capsules. The nomogram prediction model constructed based on these factors has good discrimination, calibration, and clinical applicability.
2.Effect of flipped classroom combined with case-based learning on teaching pathophysiology
Chaowei LIE ; Wentao HU ; Guangxin HU ; Guanye HU ; Haolei YUAN ; Jiayu LIN ; Junyi FU
Modern Hospital 2025;25(8):1281-1285
With the advancement of education,teaching methods have been continuously improved and optimized to en-hance students'learning experiences.In teaching the course of pathophysiology,a core discipline for medical students,integra-tion of Case-Based Learning(CBL)with the flipped classroom model can serve as a powerful pedagogical tool by stimulating students'interest,promoting collaborative learning,enhancing teacher-student interaction,and fostering a more active and en-gaging classroom environment.It also equips students with the confidence to better address real-world medical scenarios.This pa-per examines the application effect of the integrated teaching method on the teaching of pathophysiology and evaluates its pedagog-ical effectiveness.
3.Comparison of Prognosis between Differentiated and Common Bladder Urothelial Carcinoma
Yuan SHUI ; Longhui LAI ; Wentao MA
Journal of Medical Research 2025;54(2):110-116
Objective To compare the prognosis of differentiated bladder urothelial carcinoma(BUC)and common BUC.Methods A retrospective study was conducted to select the clinical data of 236 patients with common BUC and 40 patients with differentiated BUC who underwent radical cystectomy for muscular invasive bladder cancer from January 2012 to March 2023 in the Second Hospital of Lanzhou University.A propensity score matching(PSM)method was used to reduce selection bias in observational studies.The Kaplan-Meier method was used to compare overall survival(OS)and disease-specific survival(CSS)between the two groups.The COX propor-tional risk model was used to analyze the effect of differentiated BUC on overall mortality risk(OMR)and cancer-specific mortality risk(CSMR).Results The median follow-up time was 30.5months,ranged from 4months to 134months.Before PSM,there were signifi-cant differences in overall mortality(OM)and cancer-specific mortality(CSM)between the differentiated BUC and the common BUC(P were 0.008,0.011).The Kaplan-Meier survival curve analysis showed the OS(P=0.020)and CSS(P=0.023)of common BUC were better than those of differentiated BUC.Multivariate COX regression analysis showed that the OMR and CSMR of differentiated BUC increased by 75%(P=0.013)and 79%(P=0.029)compared with common BUC.After PSM,there was no significant difference in OM(P=0.217)and CSM(P=0.134)between the two groups.Kaplan-Meier survival curve analysis showed that there was no signifi-cant difference in OS(P=0.510)and CSS(P=0.340)between common BUCand differentiated BUC.Multivariate COX regression a-nalysis showed that there were no significant differences in OMR and CSMR between the two groups(all P>0.05).Conclusion After PSM,the prognosis of differentiated BUC was not found to be inferior to that of the common BUC.Furthermore,the specific type of differ-entiation was not identified as an individual predictor of a worse prognosis.
4.Clinical analysis of five cases of neuronal intranuclear inclusion disease with voiding dysfunction as the initial symptom
Zhihao YUAN ; Guifang SUN ; Wentao HU ; Lihui WANG ; Qi LI ; Xuechao ZHAO ; Liang YAN ; Baoping QIAO
Chinese Journal of Urology 2025;46(5):389-391
Neuronal intranuclear inclusion disease(NIID)is a rare hereditary neurodegenerative disorder that can affect multiple systems. However,it is uncommon for urinary dysfunction to be the initial symptom. This article reports five cases. The five patients began to experience voiding dysfunction such as frequent urination,weak urination,and incomplete urination at the mean ages of 55.4(47 - 65)years old. Four months to twelve years after urinary onset,neurological symptoms such as headache,memory decline,transient loss of consciousness,and unsteady gait began to appear. Four of the five cases had a family history. Brain MRI revealed the “ribbon sign” or “crest sign” in all cases. Skin biopsy revealed eosinophilic inclusions in the cell nuclei,and NOTCH2NLC gene testing identified abnormal GGC mutations. Three of the five patients underwent cystostomy due to secondary hydronephrosis,while the other two received no special treatment. After a follow-up of 18 to 35 months since diagnosis,the patients who underwent cystostomy had normal renal function. Neurological symptoms in all five patients worsened to varying degrees.
5.A novel integrated model combining CT body composition and inflammation-nutrition indices for predicting the complications of obstructive colorectal cancer patients
Zhenying XU ; Wentao XIE ; Yuan GAO ; Wenzhi WU ; Mingyu YANG ; Tianxu MA ; Hanyu YANG ; Yun LU
Chinese Journal of Surgery 2025;63(10):911-919
Objective:To investigate the impact of body composition and inflammatory nutritional indicators on postoperative complications in patients with obstructive colorectal cancer,and to develop and validate a nomogram model.Methods:This is a retrospective case series study. The clinical data of 293 patients with obstructive colorectal cancer who were treated at the Department of Gastrointestinal Surgery,the Affiliated Hospital of Qingdao University,between January 2016 and January 2024,were retrospectively collected. The cohort included 182 males and 111 females,aged (65.0±12.1) years (range: 18 to 80 years). The dataset was randomly divided into a training group ( n=196) and a validation group ( n=97) with a 7∶3 ratio. Independent sample t test and multivariate logistic regression analysis were employed to identify independent risk factors associated with postoperative complications in patients with obstructive colorectal cancer. A preoperative nomogram model was subsequently developed for predicting postoperative complications,which was further validated using a validation cohort. Results:The training group comprised 119 males and 77 females,with 68 cases experiencing postoperative complications and 128 cases without complications. The validation group included 63 males and 34 females,with 30 cases experiencing postoperative complications and 67 cases without complications.Univariate analysis and multivariate analysis revealed that low skeletal muscle index ( OR=0.867,95% CI: 0.795 to 0.947),high visceral fat index ( OR=1.058,95% CI: 1.028 to 1.089),high systemic immune inflammation index ( OR=1.002, 95% CI: 1.000 to 1.003), low prognostic nutritional index ( OR=0.847,95% CI: 0.782 to 0.917),and preoperative anemia ( OR=2.714,95% CI: 1.161 to 6.344) were independent risk factors for postoperative complications (all P<0.05). A nomogram prediction model based on these five indicators was established. The area under the receiver operating characteristic (ROC) curve for the prediction model was 0.878 (95% CI: 0.829 to 0.928) in the training group and 0.849 (95% CI:0.767 to 0.930) in the validation group. Conclusions:The preoperative nomogram model,which incorporates inflammatory and nutritional indicators,demonstrates a good accuracy in predicting postoperative complications for patients with obstructive colorectal cancer. This model can effectively assist in guiding treatment decisions.
6.Differences in clinical-pathological-ultrasound features among hepatocellular carcinoma with different des-gamma-carboxy prothrombin status
Feihang WANG ; Yadan XU ; Yanni CHEN ; Kai YUAN ; Wentao KONG ; Yi DONG ; Yijie QIU ; Wenping WANG
Chinese Journal of Ultrasonography 2025;34(8):662-669
Objective:To explore the differences between clinical-pathological-ultrasound features in hepatocellular carcinoma(HCC)with negative and positive des-gamma-carboxy prothrombin(DCP).Methods:A retrospective analysis was conducted on 649 patients with pathologically confirmed HCC at Zhongshan Hospital,Fudan University from April 2020 to May 2024. Patients were stratified into DCP-negative(177 cases,<40 mAU/ml)and DCP-positive(472 cases,≥40 mAU/ml)groups. Clinical data,pathological features,and ultrasound findings were collected. Conventional ultrasound and contrast-enhanced ultrasound(CEUS)imaging characteristics were analyzed and compared between the two groups,and the correlation between ultrasound features and pathological characteristics were analyzed.Results:The DCP-negative group exhibited a lower incidence of microvascular invasion(10.17% vs. 34.75%, P<0.001)and smaller median tumor diameter(23 mm vs. 40 mm, P<0.001). Heterogeneous internal echogenicity was less frequent in DCP-negative tumors[48.59%(86/177) vs. 74.58%(352/472), P<0.001]. CEUS revealed higher rates of arterial-phase iso-enhancement(6.78% vs. 1.69%)and absence of washout(13.56% vs. 4.45%)in DCP-negative HCC(both P<0.001). CEUS LI-RADS classification showed fewer LR-5 lesions[50.85%(90/177) vs. 59.53%(281/472)]in DCP-negative group( P<0.001). Conclusions:HCC with different DCP states has different clinical-pathological-ultrasound features. DCP-negative HCCs are more likely to show atypical enhancement patterns characteristic of HCC.
7.A phase Ⅲ clinical study to evaluate the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of adults with chronic hepatitis C
Lai WEI ; Jia SHANG ; Xuan AN ; Guoqiang ZHANG ; Yujuan GUAN ; Hongxin PIAO ; Jinglan JIN ; Lang BAI ; Xingxiang YANG ; Daokun YANG ; Xinhua LUO ; Shufang YUAN ; Yingren ZHAO ; Yingjie MA ; Guangming LI ; Feng LIN ; Xiaoping WU ; Jiawei GENG ; Guizhou ZOU ; Jiabao CHANG ; Zuojiong GONG ; Xiaorong MAO ; Jing ZHU ; Wentao GUO ; Qingwei HE ; Lin LUO ; Yulei ZHUANG ; Hongming XIE ; Yingjun ZHANG
Chinese Journal of Hepatology 2025;33(6):560-569
Objective:To assess the efficacy and safety profile of antaitasvir phosphate combined with yiqibuvir in the treatment of chronic hepatitis C (CHC) of various genotypes, without cirrhosis or with compensated cirrhosis.Methods:394 cases with CHC from 22 centers were collected from October 2021 to April 2023. They were randomly assigned to receive either the experimental drugs (antaitasvir phosphate 100 mg+yiqibuvir 600 mg) or placebo treatment in a 3∶1 ratio. The patients were administered drugs once a day for 12 consecutive weeks, and then followed up for 24 weeks after treatment cessation. All subjects were unblinded at the four-week follow-up following drug discontinuation, with the experimental drug group continuing to complete subsequent post-discontinuation follow-up. The placebo group was switched to receive the experimental drugs for a repeated 12-week treatment period and followed up for another 24 weeks after discontinuation of the drug (placebo delayed treatment phase).The sustained virologic response rate (SVR12) was observed for subjects in the double-blind phase and the placebo delayed-treatment phase at 12 weeks after treatment cessation.Virological resistance analysis was performed on subjects who failed treatment. The primary efficacy endpoint was SVR12. The number and percentage of subjects who achieved "HCV RNA
8.Comparison of Prognosis between Differentiated and Common Bladder Urothelial Carcinoma
Yuan SHUI ; Longhui LAI ; Wentao MA
Journal of Medical Research 2025;54(2):110-116
Objective To compare the prognosis of differentiated bladder urothelial carcinoma(BUC)and common BUC.Methods A retrospective study was conducted to select the clinical data of 236 patients with common BUC and 40 patients with differentiated BUC who underwent radical cystectomy for muscular invasive bladder cancer from January 2012 to March 2023 in the Second Hospital of Lanzhou University.A propensity score matching(PSM)method was used to reduce selection bias in observational studies.The Kaplan-Meier method was used to compare overall survival(OS)and disease-specific survival(CSS)between the two groups.The COX propor-tional risk model was used to analyze the effect of differentiated BUC on overall mortality risk(OMR)and cancer-specific mortality risk(CSMR).Results The median follow-up time was 30.5months,ranged from 4months to 134months.Before PSM,there were signifi-cant differences in overall mortality(OM)and cancer-specific mortality(CSM)between the differentiated BUC and the common BUC(P were 0.008,0.011).The Kaplan-Meier survival curve analysis showed the OS(P=0.020)and CSS(P=0.023)of common BUC were better than those of differentiated BUC.Multivariate COX regression analysis showed that the OMR and CSMR of differentiated BUC increased by 75%(P=0.013)and 79%(P=0.029)compared with common BUC.After PSM,there was no significant difference in OM(P=0.217)and CSM(P=0.134)between the two groups.Kaplan-Meier survival curve analysis showed that there was no signifi-cant difference in OS(P=0.510)and CSS(P=0.340)between common BUCand differentiated BUC.Multivariate COX regression a-nalysis showed that there were no significant differences in OMR and CSMR between the two groups(all P>0.05).Conclusion After PSM,the prognosis of differentiated BUC was not found to be inferior to that of the common BUC.Furthermore,the specific type of differ-entiation was not identified as an individual predictor of a worse prognosis.
9.Clinical analysis of five cases of neuronal intranuclear inclusion disease with voiding dysfunction as the initial symptom
Zhihao YUAN ; Guifang SUN ; Wentao HU ; Lihui WANG ; Qi LI ; Xuechao ZHAO ; Liang YAN ; Baoping QIAO
Chinese Journal of Urology 2025;46(5):389-391
Neuronal intranuclear inclusion disease(NIID)is a rare hereditary neurodegenerative disorder that can affect multiple systems. However,it is uncommon for urinary dysfunction to be the initial symptom. This article reports five cases. The five patients began to experience voiding dysfunction such as frequent urination,weak urination,and incomplete urination at the mean ages of 55.4(47 - 65)years old. Four months to twelve years after urinary onset,neurological symptoms such as headache,memory decline,transient loss of consciousness,and unsteady gait began to appear. Four of the five cases had a family history. Brain MRI revealed the “ribbon sign” or “crest sign” in all cases. Skin biopsy revealed eosinophilic inclusions in the cell nuclei,and NOTCH2NLC gene testing identified abnormal GGC mutations. Three of the five patients underwent cystostomy due to secondary hydronephrosis,while the other two received no special treatment. After a follow-up of 18 to 35 months since diagnosis,the patients who underwent cystostomy had normal renal function. Neurological symptoms in all five patients worsened to varying degrees.
10.Construction and identification of a sizeable naive human Fab phage display antibody library
Yakun ZHAO ; Xiaoyue WEI ; Fanliang MENG ; Wentao LIU ; Jiaming FAN ; Lijin LONG ; Wanting WANG ; Jianling CHEN ; Jianzhong ZHANG ; Lihua HE ; Liyong LIU ; Rui ZHAO ; Di SUN ; Xuezhen YUAN ; Xiaomei YAN
Chinese Journal of Epidemiology 2025;46(2):288-295
Objective:To construct a sizeable naive human Fab phage display antibody library to screen high-affinity specific antibodies in vitro. Methods:Total RNA was extracted from peripheral blood mononuclear cells (PBMCs) of 126 healthy individuals, subsequently reverse-transcribed into cDNA, and used as a template. PCR amplification was performed to obtain the V H from IgG, IgM and light chain κ, λ, separately, with the initial PCR products serving as templates for a second round of PCR. Overlap extension PCR was employed to generate fragments of the κ and λ light chains. These fragments were ligated with the phage vector pNC3, which harbors the variable region 1 of the heavy chain, to construct a recombinant phage plasmid. This plasmid was then electroporated into competent Escherichia Coli TG1 cells to establish a naive human Fab phage display antibody library. One hundred clones were randomly selected for identification and sequencing, and antibody gene polymorphisms were analyzed using the IMGT database and MAFFT software. Recombinant α-hemolysin from Staphylococcus aureus was utilized to screen Fab antibody fragments through biopanning of the antibody library, followed by random selection of phage ELISA-identified clones. The positive clones (antigen A450∶blank control A450≥2.1) were sequenced. Results:Two large naive Fab phage display antibody libraries were successfully constructed, in which the capacity of κ and λ chain antibody libraries were 1.25×10 11 and 1.54×10 11, respectively. The titers for two antibody libraries were 6.04×10 13 CFU/ml and 3.50×10 13 CFU/ml. The positive transformation insertion rates for κ and λ chain antibody libraries were 96% (96/100) and 100% (100/100), respectively. Sequence analysis revealed that all antibody sequences were unique. The amino acid sequences in the skeletal region were relatively conserved. In contrast, significant variations in the length of the complementarity determining region (CDR) were found, and the diversity of amino acid sequence of the complementary determining region was high, especially the CDR3. Analysis using the IMGT database indicated that the sequences exhibited a broad distribution across variable-diversity-joining gene families. After six rounds of panning, specific phage antibodies enrichment targeting α-hemolysin were achieved. A total of 142 monoclonal antibodies were sequenced, yielding 8 distinct Fab antibody sequences. Conclusion:This study successfully constructed two naive human Fab phage display antibody libraries with large capacity and good diversity, which can be used for screening human antibodies for serum epidemiology.

Result Analysis
Print
Save
E-mail